International Association for the Study of Lung Cancer (IASLC)

The International Association for the Study of Lung Cancer (IASLC) is a global organization dedicated to the study and eradication of lung cancer and other thoracic malignancies. It provides resources such as journals, research alerts, and educational materials to support the scientific and medical community in lung cancer research and treatment. The IASLC is dedicated to the study and eradication of lung cancer and other thoracic malignancies. It provides resources including journals and articles on lung cancer epidemiology, screening, prevention, diagnosis, therapy, and clinical trials. IASLC is a global organization dedicated to the study and advancement of lung cancer research, clinical care, and patient advocacy. It partners with over 13 advocacy organizations to improve quality of care and quality of life for lung cancer patients through patient-driven initiatives. The IASLC provides educational resources, hosts conferences, and supports patient advocacy efforts worldwide. It provides educational events, research projects, and publications to advance lung cancer science. Members include oncologists, thoracic oncology specialists, nurses, scientists, pathologists, radiologists, pulmonologists, statisticians, patient research advocates, patients, and caregivers. The IASLC is a global organization dedicated to the study and treatment of lung cancer and thoracic malignancies. It supports research, education, and advocacy to improve patient outcomes and advance scientific knowledge in thoracic oncology.